TP53 and posterior cortical atrophy: For example, in patients with high-risk localized PCa receiving anti-androgen therapies before prostatectomy, whole-exome and -transcriptome sequencing of pretreatment tumors showed that TP53 alterations were exclusively found in non-responders to neoadjuvant therapy [71].